{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:30:57Z","timestamp":1792521057763,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":30,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Dutch Research Council","doi-asserted-by":"publisher","award":["15204"],"award-info":[{"award-number":["15204"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jconrel.2024.07.044","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T05:23:54Z","timestamp":1721885034000},"page":"481-492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Biofluid specific protein coronas affect lipid nanoparticle behavior in vitro"],"prefix":"10.1016","volume":"373","author":[{"given":"Demian","family":"van Straten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Sork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luuk","family":"van de Schepop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowan","family":"Frunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kariem","family":"Ezzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond M.","family":"Schiffelers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jconrel.2024.07.044_bb0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrd2742","article-title":"Knocking down barriers: advances in siRNA delivery","volume":"8","author":"Whitehead","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.jconrel.2024.07.044_bb0010","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/nat.2018.0721","article-title":"Lipid nanoparticles enabling gene therapies: from concepts to clinical utility","volume":"28","author":"Kulkarni","year":"2018","journal-title":"Nucleic Acid Ther."},{"issue":"6","key":"10.1016\/j.jconrel.2024.07.044_bb0015","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","article-title":"The current landscape of nucleic acid therapeutics","volume":"16","author":"Kulkarni","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.044_bb0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.044_bb0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/jcph.1480","article-title":"Patisiran pharmacokinetics, pharmacodynamics, and exposure-response analyses in the phase 3 APOLLO trial in patients with hereditary transthyretin-mediated (hATTR) amyloidosis","volume":"60","author":"Zhang","year":"2020","journal-title":"J. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.jconrel.2024.07.044_bb0030","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nnano.2012.207","article-title":"Biomolecular coronas provide the biological identity of nanosized materials","volume":"7","author":"Monopoli","year":"2012","journal-title":"Nat. Nanotechnol."},{"issue":"9","key":"10.1016\/j.jconrel.2024.07.044_bb0035","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1021\/acs.bioconjchem.0c00366","article-title":"The biomolecular Corona of lipid nanoparticles for gene therapy","volume":"31","author":"Francia","year":"2020","journal-title":"Bioconjug. Chem."},{"issue":"52","key":"10.1016\/j.jconrel.2024.07.044_bb0040","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.jconrel.2024.07.044_bb0045","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol. Therapy: J. American Soci. Gene Therapy"},{"issue":"18","key":"10.1016\/j.jconrel.2024.07.044_bb0050","doi-asserted-by":"crossref","first-page":"8760","DOI":"10.1039\/C8NR09855G","article-title":"The role of surface chemistry in serum protein corona-mediated cellular delivery and gene silencing with lipid nanoparticles","volume":"11","author":"Chen","year":"2019","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.044_bb0055","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1038\/s41467-020-18237-7","article-title":"Mapping and identification of soft corona proteins at nanoparticles and their impact on cellular association","volume":"11","author":"Mohammad-Beigi","year":"2020","journal-title":"Nat. Commun."},{"issue":"38","key":"10.1016\/j.jconrel.2024.07.044_bb0060","doi-asserted-by":"crossref","first-page":"6026","DOI":"10.1039\/C8TB01634H","article-title":"Nanoparticle-proteome in vitro and in vivo","volume":"6","author":"Wang","year":"2018","journal-title":"J. Mater. Chem. B"},{"issue":"5","key":"10.1016\/j.jconrel.2024.07.044_bb0065","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.bbagen.2019.02.012","article-title":"A health concern regarding the protein corona, aggregation and disaggregation","volume":"1863","author":"Falahati","year":"2019","journal-title":"Biochim. Biophys. Acta, Gen. Subj."},{"key":"10.1016\/j.jconrel.2024.07.044_bb0070","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3762\/bjnano.11.25","article-title":"Interactions at the cell membrane and pathways of internalization of nano-sized materials for nanomedicine","volume":"11","author":"Francia","year":"2020","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.jconrel.2024.07.044_bb0075","first-page":"1","article-title":"The protein corona from nanomedicine to environmental science","author":"Mahmoudi","year":"2023","journal-title":"Nat. Rev. Mater."},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.044_bb0080","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.1021\/acsnano.0c10064","article-title":"Apolipoprotein E binding drives structural and compositional rearrangement of mRNA-containing lipid nanoparticles","volume":"15","author":"Sebastiani","year":"2021","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.044_bb0085","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.044_bb0090","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1039\/D0BM01609H","article-title":"Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver","volume":"9","author":"Zhang","year":"2021","journal-title":"Biomater. Sci."},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.044_bb0095","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1021\/acs.biomac.5b00108","article-title":"Protein corona of nanoparticles: distinct proteins regulate the cellular uptake","volume":"16","author":"Ritz","year":"2015","journal-title":"Biomacromolecules"},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.044_bb0100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ab.2011.06.018","article-title":"Comprehensive proteomic analysis of mineral nanoparticles derived from human body fluids and analyzed by liquid chromatography-tandem mass spectrometry","volume":"418","author":"Martel","year":"2011","journal-title":"Anal. Biochem."},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.044_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175871","article-title":"The nanoparticle protein corona formed in human blood or human blood fractions","volume":"12","author":"Lundqvist","year":"2017","journal-title":"PLoS One"},{"issue":"52","key":"10.1016\/j.jconrel.2024.07.044_bb0110","doi-asserted-by":"crossref","first-page":"23668","DOI":"10.1002\/anie.202008175","article-title":"Quantitative protein Corona composition and dynamics on carbon nanotubes in biological environments","volume":"59","author":"Pinals","year":"2020","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2024.07.044_bb0115","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3389\/fphar.2019.00724","article-title":"Gene therapy tools for brain diseases","volume":"10","author":"Ingusci","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.044_bb0120","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/cpt.2543","article-title":"Gene therapy for rare neurological disorders","volume":"111","author":"Flotte","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.jconrel.2024.07.044_bb0125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrneurol.2013.56","article-title":"Progress in gene therapy for neurological disorders","volume":"9","author":"Simonato","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"7","key":"10.1016\/j.jconrel.2024.07.044_bb0130","doi-asserted-by":"crossref","first-page":"7292","DOI":"10.1021\/acsnano.8b03500","article-title":"Evolution of nanoparticle protein Corona across the blood-brain barrier","volume":"12","author":"Cox","year":"2018","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.jconrel.2024.07.044_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202101202","article-title":"Functional siRNA delivery by extracellular vesicle-liposome hybrid nanoparticles","volume":"11","author":"Evers","year":"2022","journal-title":"Adv. Healthc. Mater."},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.044_bb0140","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1021\/acs.nanolett.1c00094","article-title":"Natural or synthetic RNA delivery: a stoichiometric comparison of extracellular vesicles and synthetic nanoparticles","volume":"21","author":"Murphy","year":"2021","journal-title":"Nano Lett."},{"issue":"3","key":"10.1016\/j.jconrel.2024.07.044_bb0145","article-title":"Nanoparticles in the clinic: an update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng. & Translat. Med."},{"key":"10.1016\/j.jconrel.2024.07.044_bb0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12014-019-9229-1","article-title":"Affinity depletion versus relative protein enrichment: a side-by-side comparison of two major strategies for increasing human cerebrospinal fluid proteome coverage","volume":"16","author":"Jankovska","year":"2019","journal-title":"Clin. Proteomics"},{"key":"10.1016\/j.jconrel.2024.07.044_bb0155","article-title":"Time evolution of PEG-shedding and serum protein coronation determines the cell uptake kinetics and delivery of lipid nanoparticle formulated mRNA","author":"Gallud","year":"2021","journal-title":"bioRxiv"},{"issue":"10","key":"10.1016\/j.jconrel.2024.07.044_bb0160","doi-asserted-by":"crossref","first-page":"11107","DOI":"10.1021\/acsnano.9b03824","article-title":"Corona composition can affect the mechanisms cells use to internalize nanoparticles","volume":"13","author":"Francia","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.07.044_bb0165","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3762\/bjnano.10.101","article-title":"Serum type and concentration both affect the protein-corona composition of PLGA nanoparticles","volume":"10","author":"Partikel","year":"2019","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.jconrel.2024.07.044_bb0170","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1039\/C9NA00537D","article-title":"Isolation methods for particle protein corona complexes from protein-rich matrices","volume":"2","author":"B\u00f6hmert","year":"2020","journal-title":"Nanoscale Adv."},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.044_bb0175","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1021\/acscentsci.9b01222","article-title":"Unbiased identification of the liposome protein Corona using Photoaffinity-based Chemoproteomics","volume":"6","author":"Pattipeiluhu","year":"2020","journal-title":"ACS Cent. Sci."},{"issue":"11","key":"10.1016\/j.jconrel.2024.07.044_bb0180","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1021\/acs.analchem.1c05243","article-title":"Isolation methods influence the protein Corona composition on gold-coated Iron oxide nanoparticles","volume":"94","author":"Hoang","year":"2022","journal-title":"Anal. Chem."},{"issue":"3","key":"10.1016\/j.jconrel.2024.07.044_bb0185","article-title":"A size-exclusion-based approach for purifying extracellular vesicles from human plasma","volume":"1","author":"Vanderboom","year":"2021","journal-title":"Cell Report. Meth."},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.044_bb0190","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.clineuro.2008.12.004","article-title":"A modern approach to CSF analysis: pathophysiology, clinical application, proof of concept and laboratory reporting","volume":"111","author":"Regeniter","year":"2009","journal-title":"Clin. Neurol. Eurosurg."},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.044_bb0195","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jprot.2010.11.010","article-title":"Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics","volume":"74","author":"Kroksveen","year":"2011","journal-title":"J. Proteome"},{"key":"10.1016\/j.jconrel.2024.07.044_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134306","article-title":"Peripheral versus central nervous system APOE in Alzheimer\u2019s disease: interplay across the blood-brain barrier","volume":"708","author":"Chernick","year":"2019","journal-title":"Neurosci. Lett."},{"issue":"12","key":"10.1016\/j.jconrel.2024.07.044_bb0205","article-title":"Influence of polyethylene glycol lipid desorption rates on pharmacokinetics and pharmacodynamics of siRNA lipid nanoparticles. Molecular therapy","volume":"2","author":"Mui","year":"2013","journal-title":"Nucleic Acids"},{"issue":"7","key":"10.1016\/j.jconrel.2024.07.044_bb0210","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.7150\/thno.18136","article-title":"Surface De-PEGylation controls nanoparticle-mediated siRNA delivery in vitro and in vivo","volume":"7","author":"Zhu","year":"2017","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.jconrel.2024.07.044_bb0215","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nbt.2614","article-title":"Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling","volume":"31","author":"Sahay","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.044_bb0220","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1038\/s41467-019-12275-6","article-title":"Linkage between endosomal escape of LNP-mRNA and loading into EVs for transport to other cells","volume":"10","author":"Maugeri","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.044_bb0225","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/s41598-020-57943-6","article-title":"Understanding the lipid and protein Corona formation on different sized polymeric nanoparticles","volume":"10","author":"Lima","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.044_bb0230","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3390\/pharmaceutics12020113","article-title":"Effect of protein Corona on the transfection efficiency of lipid-coated graphene oxide-based cell transfection reagents","volume":"12","author":"Quagliarini","year":"2020","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.044_bb0235","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202110137","article-title":"Endosomal escape of delivered mRNA from endosomal recycling tubules visualized at the nanoscale","volume":"221","author":"Paramasivam","year":"2022","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.jconrel.2024.07.044_bb0240","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41565-018-0344-3","article-title":"Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles","volume":"14","author":"Vu","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2024.07.044_bb0245","first-page":"182","article-title":"Apolipoproteins and their subspecies in human cerebrospinal fluid and plasma","volume":"6","author":"Koch","year":"2017","journal-title":"Alzheimer\u2019s & Dementia (Amsterdam, Netherlands)"},{"issue":"10","key":"10.1016\/j.jconrel.2024.07.044_bb0250","first-page":"1802199","article-title":"Prevention of Dominant IgG Adsorption on Nanocarriers in IgG-Enriched Blood Plasma by Clusterin Precoating","volume":"vol. 6","author":"Prozeller","year":"2019","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"10.1016\/j.jconrel.2024.07.044_bb0255","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cca.2019.10.027","article-title":"Potential clinical applications of the personalized, disease-specific protein corona on nanoparticles","volume":"501","author":"Garc\u00eda Vence","year":"2020","journal-title":"Clini. Chim. Acta; Int. J. Clin. Chem."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.044_bb0260","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1039\/C6NR05609A","article-title":"A protein corona-enabled blood test for early cancer detection","volume":"9","author":"Caputo","year":"2017","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.044_bb0265","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/pharmaceutics11010031","article-title":"Protein Corona fingerprints of liposomes: new opportunities for targeted drug delivery and early detection in pancreatic Cancer","volume":"11","author":"Palchetti","year":"2019","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.044_bb0270","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1038\/s41467-020-17033-7","article-title":"Rapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona","volume":"11","author":"Blume","year":"2020","journal-title":"Nat. Commun."},{"issue":"32","key":"10.1016\/j.jconrel.2024.07.044_bb0275","doi-asserted-by":"crossref","first-page":"16697","DOI":"10.1039\/D0NR03439H","article-title":"A protein corona sensor array detects breast and prostate cancers","volume":"12","author":"Digiacomo","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2024.07.044_bb0280","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.biocel.2015.09.002","article-title":"Personalized liposome-protein corona in the blood of breast, gastric and pancreatic cancer patients","volume":"75","author":"Colapicchioni","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jconrel.2024.07.044_bb0285","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.colsurfb.2014.10.008","article-title":"Size and charge of nanoparticles following incubation with human plasma of healthy and pancreatic cancer patients","volume":"123","author":"Caracciolo","year":"2014","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"11","key":"10.1016\/j.jconrel.2024.07.044_bb0290","doi-asserted-by":"crossref","first-page":"15723","DOI":"10.1021\/acsnano.0c06679","article-title":"Person-specific biomolecular coronas modulate nanoparticle interactions with immune cells in human blood","volume":"14","author":"Ju","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.07.044_bb0295","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1039\/C9NH00097F","article-title":"Disease-specific protein corona sensor arrays may have disease detection capacity","volume":"4","author":"Caracciolo","year":"2019","journal-title":"Nanoscale Horiz."},{"issue":"24","key":"10.1016\/j.jconrel.2024.07.044_bb0300","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1021\/acs.biochem.3c00371","article-title":"Lipid nanoparticles deliver mRNA to the brain after an intracerebral injection","volume":"62","author":"Tuma","year":"2023","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2024.07.044_bb0305","first-page":"773","article-title":"Lipid nanoparticle delivery limits antisense oligonucleotide activity and cellular distribution in the brain after intracerebroventricular injection","volume":"32","author":"Byrnes","year":"2023","journal-title":"Mol. Therap.: Nucleic Acids"},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.044_bb0310","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/jnc.15350","article-title":"Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies","volume":"158","author":"Schmid","year":"2021","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.044_bb0315","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/jnc.13399","article-title":"Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer\u2019s disease, dementia with Lewy bodies, and frontotemporal lobar degeneration","volume":"136","author":"Ishiki","year":"2016","journal-title":"J. Neurochem."},{"issue":"11\u221212","key":"10.1016\/j.jconrel.2024.07.044_bb0320","article-title":"Decreased neuro-axonal proteins in CSF at first attack of suspected multiple sclerosis","volume":"11","author":"Stoop","year":"2017","journal-title":"Proteomics Clin. Appl."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.044_bb0325","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s43587-023-00550-7","article-title":"Cerebrospinal fluid proteomics in patients with Alzheimer\u2019s disease reveals five molecular subtypes with distinct genetic risk profiles","volume":"4","author":"Tijms","year":"2024","journal-title":"Nature Aging"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924004917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924004917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T19:11:27Z","timestamp":1728501087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924004917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":65,"alternative-id":["S0168365924004917"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.044","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biofluid specific protein coronas affect lipid nanoparticle behavior in vitro","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}